Evaluation of Intestinal Parasites in Patients With Intestinal Cancer in Sohag, Egypt.

Study Overview
=================
Brief Summary
-----------------
This study aims to evaluate the intestinal parasitic infections in patients with intestinal cancer in comparison to non-cancer individuals

Detailed Description
-----------------
Intestinal parasitic infections continue to be characterized as a significant cause of morbidity worldwide, and according to World Health Organization (WHO) statistics, more than a quarter of the world's population, mostly in developing countries, are infected Acquisition of infection, clinical severity, and outcome of a parasitic disease depend on innate and acquired host immunity as well as on the parasite's response against the host when the infection is established Chronic infections and inflammation along with unhealthy diet, stressful lifestyle, cell damage, constant exposure to radiation, and harmful chemicals are risk factors for the development of cancers As infectious factors, the Blastocystis hominis and Cryptosporidium spp. are opportunistic protozoa isolated from the human host gastrointestinal tract, These prevalent enteric parasites may cause serious challenges in people undergoing colorectal cancer treatment (chemotherapy)

Official Title
-----------------
Evaluation of Intestinal Parasites in Patients With Intestinal Cancer in Sohag, Egypt.

Conditions
-----------------
Intestinal Parasites in Patients With Intestinal Cancer

Intervention / Treatment
-----------------
* Diagnostic Test: stool examination


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: intestinal cancer patients (colorectal cancer, intestinal lymphoma, gastrointestinal stromal tumors, and other malignant variants) Exclusion Criteria: patient took antibiotics within the previous four weeks and anti-parasitic drugs within the previous two weeks

Ages Eligible for Study
-----------------
Minimum Age: 2 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| group A<br>• One hundred stool samples will be collected from patients with intestinal cancer admitted to Sohag Hospital. | Diagnostic Test: stool examination<br>* Each collected sample will be divided into three parts; 1st part will be examined freshly without preservatives by macroscopic and microscopic examination, the 2nd part will be preserved for concentration techniques, staining, and microscopic examination and the 3rd part will be cultivated for Strongyloides stercoralis diagnosis<br>|
| group B<br>one hundred stool samples will be collected from the control group of patients who attended outpatient clinics | Diagnostic Test: stool examination<br>* Each collected sample will be divided into three parts; 1st part will be examined freshly without preservatives by macroscopic and microscopic examination, the 2nd part will be preserved for concentration techniques, staining, and microscopic examination and the 3rd part will be cultivated for Strongyloides stercoralis diagnosis<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| evaluate the intestinal parasitic infections in patients with intestinal cancer in comparison to non-cancer individuals | • Each collected sample will be divided into three parts; 1st part will be examined freshly without preservatives by macroscopic and microscopic examination, the 2nd part will be preserved for concentration techniques, staining, and microscopic examination and the 3rd part will be cultivated for Strongyloides stercoralis diagnosis | 12 months |